-
-
-
-
-
-
-
ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance
-
-
-
-
-
-
-
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares
-
-
-
-
-
-
-
ANI Pharma (ANIP) Announces FDA Approval for Expansion of ILUVIEN Label
-
-
-
-
-
-
-
ANI Pharma (ANIP) Reports Prelim Q4, 2025 Outlook
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
-
-
-
-
-
-
-
ANI Pharma (ANIP) Closes Acquisition of Alimera Sciences (ALIM)
-
1,185,405 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

